AR087209A2 - Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico - Google Patents

Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico

Info

Publication number
AR087209A2
AR087209A2 ARP120102582A ARP120102582A AR087209A2 AR 087209 A2 AR087209 A2 AR 087209A2 AR P120102582 A ARP120102582 A AR P120102582A AR P120102582 A ARP120102582 A AR P120102582A AR 087209 A2 AR087209 A2 AR 087209A2
Authority
AR
Argentina
Prior art keywords
methyl
bencimidazol
preparation
bifenil
ilmetil
Prior art date
Application number
ARP120102582A
Other languages
English (en)
Inventor
Norbert Hauel
Rolf Dach
Helmut Heitger
Oliver Meyer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33016100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR087209(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR087209A2 publication Critical patent/AR087209A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Reivindicación 1: Procedimiento para la preparación de telmisartan, caracterizado porque (a) 2-n-propil-4-metil-6-(1’-metilbencimidazol-2’-il)-bencimidazol de fórmula (1) se hace reaccionar con un compuesto de la fórmula general (2) en la cual Z representa un grupo lábil, y el compuesto así obtenido, en caso deseado, se somete a una elaboración, (b) el grupo ciano del compuesto, así obtenido, 2-ciano-4’-[2’’-n-propil-4’’-metil-6’’-(1’’’-metilbencimidazol-2’’’-il)-bencimidazol-1’’-il-metil]bifenilo de fórmula (3) se transforma a continuación por hidrólisis en la función ácido, y el telmisartan, así obtenido, se transforma durante la elaboración, en caso deseado, en el hidrocloruro.
ARP120102582A 2003-03-31 2012-07-17 Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico AR087209A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10314702A DE10314702A1 (de) 2003-03-31 2003-03-31 Verfahren zur Herstellung von Telmisartan

Publications (1)

Publication Number Publication Date
AR087209A2 true AR087209A2 (es) 2014-02-26

Family

ID=33016100

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP040101066A AR043794A1 (es) 2003-03-31 2004-03-31 Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico
ARP120102582A AR087209A2 (es) 2003-03-31 2012-07-17 Procedimiento para la preparacion de acido 4’-[2-n-propil-4-metil-6-(1-metil-bencimidazol-2-il)bencimidazol-1-ilmetil]-bifenil-2-carboxilico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP040101066A AR043794A1 (es) 2003-03-31 2004-03-31 Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico

Country Status (26)

Country Link
US (2) US7193089B2 (es)
EP (2) EP1611108B1 (es)
JP (1) JP5160740B2 (es)
KR (1) KR101096499B1 (es)
CN (1) CN100418953C (es)
AR (2) AR043794A1 (es)
AT (1) ATE515500T1 (es)
AU (1) AU2004226239B2 (es)
BR (1) BRPI0408861A (es)
CA (1) CA2520714C (es)
CL (1) CL2004000687A1 (es)
CY (2) CY1112020T1 (es)
DE (1) DE10314702A1 (es)
DK (2) DK1611108T3 (es)
ES (2) ES2432647T3 (es)
IL (1) IL171145A (es)
MX (1) MXPA05009529A (es)
NZ (1) NZ543244A (es)
PE (1) PE20050390A1 (es)
PL (2) PL1611108T3 (es)
PT (2) PT2322511E (es)
RU (1) RU2430092C2 (es)
SI (2) SI1611108T1 (es)
TW (1) TWI335916B (es)
UY (1) UY28246A1 (es)
WO (1) WO2004087676A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
GB2414019A (en) 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
US7501448B2 (en) * 2004-10-15 2009-03-10 Teva Pharmaceutical Industries, Ltd. Process for preparing telmisartan
WO2006044754A2 (en) 2004-10-18 2006-04-27 Dr. Reddy's Laboratories Ltd. Process for preparing telmisartan
EP1871764A1 (en) 2005-04-01 2008-01-02 LEK Pharmaceuticals D.D. A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists
ITMI20050801A1 (it) * 2005-05-03 2006-11-04 Dipharma Spa Procedimento per la preparazione di telmisartan
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
US20060264491A1 (en) * 2006-06-08 2006-11-23 Chemagis Ltd. Telmisartan production process
CN101172968B (zh) * 2006-11-01 2010-05-12 浙江天宇药业有限公司 2-正丙基-4甲基-6-(甲基苯并咪唑-2-基)苯并咪唑盐及其制备方法
CN101743228B (zh) * 2007-07-03 2014-01-29 新梅斯托克尔卡托瓦纳兹德拉韦尔公司 替米沙坦的制备方法
CZ302272B6 (cs) * 2007-07-09 2011-01-19 Zentiva, A. S. Zpusob výroby 4´-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-karboxylové kyseliny (telmisartanu)
WO2009116089A2 (en) * 2008-03-14 2009-09-24 Ipca Laboratories Limited Novel intermediates and method for synthesis of 4'-[(1,4'-dimethyl-2'-propyl-[2,6'- bi-1hbenzimidazol]-l-yl)methyl]-1,1-biphenyl]-2-carboxylic acid.
EP2103588A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. 2'-Halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
EP2103609A1 (en) * 2008-03-20 2009-09-23 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
CA2718891C (en) * 2008-03-20 2016-10-18 Lek Pharmaceuticals D.D. 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists
EP2123648A1 (en) 2008-05-20 2009-11-25 Chemo Ibérica, S.A. A process for the preparation of Telmisartan.
EP2149566A1 (en) 2008-07-15 2010-02-03 Chemo Ibérica, S.A. A process for the preparation of telmisartan
SI2443094T1 (sl) 2009-06-19 2013-08-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo telmisartana
EP2277866A1 (en) * 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2305650A1 (en) 2009-09-21 2011-04-06 Chemo Ibérica, S.A. Novel process for the preparation of telmisartan
EP2632438A1 (en) 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
CN102267949A (zh) * 2011-06-14 2011-12-07 张长利 替米沙坦制备新工艺
WO2014027280A1 (en) 2012-08-14 2014-02-20 U Amarnath Amarnath One pot process for the preparation of telmisartan
CN103787982A (zh) * 2012-10-31 2014-05-14 上海特化医药科技有限公司 制备替米沙坦的方法及其中间体
CN104557724B (zh) * 2014-11-17 2017-01-11 江苏中邦制药有限公司 替米沙坦不定形晶型及其制备方法
CN105130905B (zh) * 2015-09-17 2017-09-08 浙江金立源药业有限公司 一种替米沙坦的合成方法
CN109912512B (zh) * 2017-12-13 2023-05-30 上海科胜药物研发有限公司 一种新的替米沙坦杂质化合物及其制备方法和用途
CN112251770B (zh) * 2020-10-14 2021-07-27 湖南大学 一种抗高血压药替米沙坦中间体电化学制备新方法
CN113307775B (zh) * 2021-04-16 2022-04-22 河北戴桥医药科技有限公司 一种替米沙坦的制备方法
WO2023204729A1 (ru) * 2022-04-19 2023-10-26 Общество с ограниченной ответственностью "Гелеспон" Фармацевтические композиции на основе новой субстанции 4-[2-(1н-имидазол-4-ил)-этилкарбамоил]-бутановой кислоты и способ получения субстанции

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
DE4103492A1 (de) * 1991-02-06 1992-10-08 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US6358986B1 (en) * 1999-01-19 2002-03-19 Boehringer Ingelheim Pharma Kg Polymorphs of telmisartan
DE19901921C2 (de) * 1999-01-19 2001-01-04 Boehringer Ingelheim Pharma Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels
US6737432B2 (en) * 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan

Also Published As

Publication number Publication date
KR20050118699A (ko) 2005-12-19
CA2520714A1 (en) 2004-10-14
PT1611108E (pt) 2011-09-01
UY28246A1 (es) 2004-11-08
PL2322511T3 (pl) 2014-01-31
TWI335916B (en) 2011-01-11
CN1768044A (zh) 2006-05-03
TW200504055A (en) 2005-02-01
PT2322511E (pt) 2013-08-29
JP2006521289A (ja) 2006-09-21
ES2432647T3 (es) 2013-12-04
PL1611108T3 (pl) 2011-12-30
WO2004087676A1 (de) 2004-10-14
CL2004000687A1 (es) 2005-02-04
KR101096499B1 (ko) 2011-12-20
IL171145A (en) 2010-12-30
RU2430092C2 (ru) 2011-09-27
EP2322511B1 (de) 2013-07-31
DK2322511T3 (da) 2013-10-28
US20130137878A1 (en) 2013-05-30
SI2322511T1 (sl) 2013-10-30
JP5160740B2 (ja) 2013-03-13
EP2322511A1 (de) 2011-05-18
BRPI0408861A (pt) 2006-04-11
CY1115156T1 (el) 2016-12-14
CN100418953C (zh) 2008-09-17
EP1611108B1 (de) 2011-07-06
AU2004226239B2 (en) 2011-04-21
DE10314702A1 (de) 2004-10-21
RU2005133479A (ru) 2006-07-27
PE20050390A1 (es) 2005-06-23
DK1611108T3 (da) 2011-10-10
US20040236113A1 (en) 2004-11-25
CY1112020T1 (el) 2015-11-04
NZ543244A (en) 2010-02-26
AR043794A1 (es) 2005-08-10
EP1611108A1 (de) 2006-01-04
CA2520714C (en) 2012-05-15
AU2004226239A1 (en) 2004-10-14
SI1611108T1 (sl) 2011-10-28
ATE515500T1 (de) 2011-07-15
MXPA05009529A (es) 2005-10-19
US8993778B2 (en) 2015-03-31
ES2369081T3 (es) 2011-11-25
US7193089B2 (en) 2007-03-20

Similar Documents

Publication Publication Date Title
AR043794A1 (es) Procedimiento para la preparacion de acido 4' - [2 - n - propil-4-metil-6- (1-metil-bencimidazol-2-il) bencimidazol-1-ilmetil] - bifenil- 2 - carboxilico
PE20081737A1 (es) Procedimiento de preparacion de un derivado de benzimidazol
AR049524A1 (es) (orto-fenil)-anilidas de acido 1-metil-3-difluorometil-pirazol-4-carboxilico y su uso como fungicida
AR030947A1 (es) Guanidinas de acido cinamico substituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asi como un medicamento que las contiene
CR9145A (es) Procedimiento para intensificar la eficiencia de etaboxam
AR094588A2 (es) Proceso de obtención de un compuesto derivado de benzimidazol y composición farmacéutica
SV2004001373A (es) Inhibidores de pde9 para tratamiento de transtornos cardiovasculares. ref. pcs22051
ATE440094T1 (de) Fumagillolderivate und verfahren zu deren herstellung
UY25980A1 (es) Polimorfos de telmisartan
BR0111589A (pt) Sólido catalisador para polimerização de olefina, sólido catalisador pré-polimerizado, uso de um sólido catalisador, e, processo para preparar poliolefinas
YU36304A (sh) Kristalna natrijumova so telmisartana i njena primena kao angiotenzinskog antagonista
MX384710B (es) Proceso para preparar 3-metilciclopentadecan-1,5-diona.
BRPI0509988A (pt) processo para preparar ácido acrìlico por oxidação parcial heterogeneamente catalisada de pelo menos um composto precursor de hidrocarboneto c3
CL2012000554A1 (es) Proceso para la preparacion de artemisina a partir de un derivado de anhidro; y el compuesto intermediario considerado.
DE602004032028D1 (de) Oxy)-chinazolin-4-on
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
AR058298A1 (es) Composicion veterinaria
PE20030819A1 (es) 2'halo-3',5'-dialcoxi-fen-1'-il-imino-2-imidazolidinas
PE20080193A1 (es) PROCESO PARA LA PREPARACION DE ESTER 2-[4-(4-FLUORO-2-METIL-1H-INDOL-5-ILOXI)-5-METILPIRROLO[2,1-f][1,2,4]TRIAZIN-6-ILOXI]-1-METILETILICO DEL ACIDO (1R), 2S-2-AMINOPROPIONICO
GT200600102A (es) Procedimiento para la preparacion de compuestos benzoxazol sustituidos
AR042194A1 (es) Metodo para preparar inhibidores de fosfodiesterasa - 4
TW200801162A (en) Thulium-containing fluorescent substance for white light emitting diode and manufacturing method thereof
UY28585A1 (es) Compuestos químicos
AR026731A1 (es) Procedimiento para fabricar tienopirimidinas
UY28697A1 (es) Procedimiento para la preparación de ácidos 2-(fenoximetil)-benzoicos sustituidos

Legal Events

Date Code Title Description
FB Suspension of granting procedure